Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Ionis Pharmaceuticals, Inc. (0JDI)
Market Open
3 Jun, 15:30
LSE
All
(8)
DE
(4)
IT
(1)
MX
(1)
GB
(1)
US
(1)
NASDAQ (NGS)
Primary
LSE
XMEX
XSTU
XMUN
XDUS
XFRA
XMIL
$
73.
83
+0.93
+1.28%
$
10.11B
Market Cap
-
P/E Ratio
-
Div Yield
44
Volume
-3.43
Eps
$
72.9
Previous Close
Watching
Watch
Add Transaction
Day Range
72.5
73.83
Year Range
34.14
86.72
Want to track
0JDI
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
News
Historical Data
Ionis Pharmaceuticals, Inc. (0JDI) Statistics
Valuation metrics
Market Cap
10.11B
Enterprise value
12.6B
Trailing P/E (ttm)
-
Forward P/E
-
PEG ratio
-
Price/Sales (ttm)
-
Price/Book (mrq)
24.81
Enterprise Value/Revenue
11.91
Enterprise Value/EBITDA
-37.21
Overview
Shares outstanding
137.57M
Float
163.98M
Shares short
-
% Held by insiders
0.01%
% Held by institutions
1.07%
Average volume (10 days)
236
Average volume (90 days)
8.16K
Price summary
52-Week low
34.14
52-Week high
86.72
Beta
0.38
50-Day moving average
48.72
200-Day moving average
44.34
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
-0.31%
Operating margin
-0.48%
Operational effectiveness
Return on assets
-0.07%
Return on equity
-0.68%
Income Statement
Revenue (ttm)
1.06B
Revenue per share (ttm)
6.55
Quarterly revenue growth (yoy)
0.87%
Gross profit (ttm)
115.73M
EBITDA
-338.65M
Net income to common (ttm)
-326.98M
Diluted EPS (ttm)
-0.03
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
1.98B
Total cash per share (mrq)
11.96
Total debt (mrq)
2.61B
Total Debt/Equity (mrq)
531.05
Current ratio (mrq)
4.1%
Book value per share (mrq)
2.96
Cash Flow
Cash flow statement
-910.63M
Levered free cash flow (LFCF)
-807.8M